Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
8.97M
-
Shares change
-
+1.66M
-
Total reported value, excl. options
-
$413M
-
Value change
-
+$78.2M
-
Put/Call ratio
-
1.49
-
Number of buys
-
78
-
Number of sells
-
-42
-
Price
-
$46.08
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2021
147 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q4 2021.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.97M shares
of 22.3M outstanding shares and own 40.28% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.69M shares), VANGUARD GROUP INC (717K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (451K shares), STATE STREET CORP (438K shares), DIMENSIONAL FUND ADVISORS LP (389K shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (328K shares), Rubric Capital Management LP (308K shares), TANG CAPITAL MANAGEMENT LLC (300K shares), Global Alpha Capital Management Ltd. (285K shares), and AMERIPRISE FINANCIAL INC (283K shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.